Heart failure: now centre-stage in diabetes-Reference-Cited by-同舟云学术

Heart failure: now centre-stage in diabetes

Published:2022-10 Issue:10 Volume:10 Page:689-691
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

McMurray John J V,Sattar Naveed

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference10 articles.

1. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored;McMurray;Lancet Diabetes Endocrinol,2014

2. Heart failure: an underappreciated complication of diabetes. a consensus report of the American Diabetes Association;Pop-Busui;Diabetes Care,2022

3. Diabetic cardiomyopathy;Lee;Heart,2019

4. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

5. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines;Heidenreich;Circulation,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes;Diabetologia;2024-02-22

2. Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes;2023-08-08

3. Re-evaluation of dipeptidyl peptidase-4 inhibitors in patients with heart failure and diabetes mellitus;Diabetes Research and Clinical Practice;2023-08

4. A review of current key guidelines for managing high‐risk patients with diabetes and heart failure and future prospects;Diabetes, Obesity and Metabolism;2023-05-30